1. (a) A manufacturer operating within an eligible facility and in accordance with federal law may make available to an eligible patient the manufacturer's individualized investigational treatment from an eligible facility.
2. (b) Nothing in this chapter may be construed to require a manufacturer of an individualized investigational treatment to make the individualized investigational treatment available to an eligible patient.

3. (c) A manufacturer of an individualized investigational treatment may do any of the following:

   1. (1) Provide an individualized investigational treatment to an eligible patient without receiving compensation.
   2. (2) Require an eligible patient to pay the costs of or associated with the manufacture of the individualized investigational treatment.
4. (d) This chapter does not create a cause of action against a manufacturer of an individualized investigational treatment for any harm to an eligible patient resulting from use of an individualized investigational treatment.

As added by P.L.215-2025, SEC.30.